Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Evaluation of the published kinase inhibitor set to identify multiple inhibitors of bacterial ATP-dependent mur ligases.

Hrast M, Rožman K, Ogris I, Škedelj V, Patin D, Sova M, Barreteau H, Gobec S, Grdadolnik SG, Zega A.

J Enzyme Inhib Med Chem. 2019 Dec;34(1):1010-1017. doi: 10.1080/14756366.2019.1608981.

2.

Impact of FiuA Outer Membrane Receptor Polymorphism on the Resistance of Pseudomonas aeruginosa toward Peptidoglycan Lipid II-Targeting PaeM Pyocins.

Latino L, Patin D, Chérier D, Touzé T, Pourcel C, Barreteau H, Mengin-Lecreulx D.

J Bacteriol. 2019 Jun 10;201(13). pii: e00164-19. doi: 10.1128/JB.00164-19. Print 2019 Jul 1.

PMID:
30988031
3.

Anthranilic Acid Inhibitors of Undecaprenyl Pyrophosphate Synthase (UppS), an Essential Enzyme for Bacterial Cell Wall Biosynthesis.

Jukič M, Rožman K, Sova M, Barreteau H, Gobec S.

Front Microbiol. 2019 Jan 14;9:3322. doi: 10.3389/fmicb.2018.03322. eCollection 2018.

4.

Haloarcula sebkhae sp. nov., an extremely halophilic archaeon from Algerian hypersaline environment.

Barreteau H, Vandervennet M, Guédon L, Point V, Canaan S, Rebuffat S, Peduzzi J, Carré-Mlouka A.

Int J Syst Evol Microbiol. 2019 Mar;69(3):732-738. doi: 10.1099/ijsem.0.003211. Epub 2019 Jan 10.

PMID:
30628879
5.

A road map for prioritizing warheads for cysteine targeting covalent inhibitors.

Ábrányi-Balogh P, Petri L, Imre T, Szijj P, Scarpino A, Hrast M, Mitrović A, Fonovič UP, Németh K, Barreteau H, Roper DI, Horváti K, Ferenczy GG, Kos J, Ilaš J, Gobec S, Keserű GM.

Eur J Med Chem. 2018 Dec 5;160:94-107. doi: 10.1016/j.ejmech.2018.10.010. Epub 2018 Oct 6.

PMID:
30321804
6.

[Securing the distribution of patient-specific unit dose medication following the installation of a unit dose dispensing system: Cartography of risks a priori within a hospital pharmacy].

Martinez L, Bloch V, Jacob A, Iskra F, Barreteau H, Razurel A.

Ann Pharm Fr. 2018 Nov;76(6):473-488. doi: 10.1016/j.pharma.2018.05.004. Epub 2018 Sep 19. French.

PMID:
30243472
7.

[Temporary approval for intranasal naloxone: Setting up in a French addiction center].

Barré T, Vorspan F, Fortias M, Veyrier M, Cavagna P, Azuar J, Nicolas L, Naccache F, Barreteau H, Bellivier F, Bloch V.

Therapie. 2018 Dec;73(6):495-500. doi: 10.1016/j.therap.2018.03.003. Epub 2018 Mar 29. French.

PMID:
29680374
8.

In silico identification, synthesis and biological evaluation of novel tetrazole inhibitors of MurB.

Hrast M, Jukič M, Patin D, Tod J, Dowson CG, Roper DI, Barreteau H, Gobec S.

Chem Biol Drug Des. 2018 Jun;91(6):1101-1112. doi: 10.1111/cbdd.13172. Epub 2018 Feb 12.

PMID:
29363274
9.

An observational study of benzodiazepine prescription during inpatient alcohol detoxification for patients with vs. without chronic pretreatment with high-dosage baclofen.

Martinez L, Vorspan F, Declèves X, Azuar J, Fortias M, Questel F, Dereux A, Grichy L, Barreteau H, Bellivier F, Lépine JP, Bloch V.

Fundam Clin Pharmacol. 2018 Apr;32(2):200-205. doi: 10.1111/fcp.12339. Epub 2018 Jan 11.

PMID:
29224234
10.

Can clinical practice indicator relating to long-acting benzodiazepine use in the elderly be easily generated in a hospital setting?

Kadri B, Teixeira A, Duteil C, Tan A, Barreteau H, Segouin C, Troude P.

Eur J Clin Pharmacol. 2018 Feb;74(2):233-241. doi: 10.1007/s00228-017-2371-7. Epub 2017 Nov 16.

PMID:
29147805
11.

Discovery of new MurA inhibitors using induced-fit simulation and docking.

Rožman K, Lešnik S, Brus B, Hrast M, Sova M, Patin D, Barreteau H, Konc J, Janežič D, Gobec S.

Bioorg Med Chem Lett. 2017 Feb 15;27(4):944-949. doi: 10.1016/j.bmcl.2016.12.082. Epub 2016 Dec 31.

PMID:
28077258
12.

Pectocin M1 (PcaM1) Inhibits Escherichia coli Cell Growth and Peptidoglycan Biosynthesis through Periplasmic Expression.

Chérier D, Giacomucci S, Patin D, Bouhss A, Touzé T, Blanot D, Mengin-Lecreulx D, Barreteau H.

Antibiotics (Basel). 2016 Oct 8;5(4). pii: E36.

13.

Identification and Partial Characterization of a Novel UDP-N-Acetylenolpyruvoylglucosamine Reductase/UDP-N-Acetylmuramate:l-Alanine Ligase Fusion Enzyme from Verrucomicrobium spinosum DSM 4136(T).

Naqvi KF, Patin D, Wheatley MS, Savka MA, Dobson RC, Gan HM, Barreteau H, Blanot D, Mengin-Lecreulx D, Hudson AO.

Front Microbiol. 2016 Mar 23;7:362. doi: 10.3389/fmicb.2016.00362. eCollection 2016.

14.

Crystallographic Study of Peptidoglycan Biosynthesis Enzyme MurD: Domain Movement Revisited.

Šink R, Kotnik M, Zega A, Barreteau H, Gobec S, Blanot D, Dessen A, Contreras-Martel C.

PLoS One. 2016 Mar 31;11(3):e0152075. doi: 10.1371/journal.pone.0152075. eCollection 2016.

15.

Unusual substrate specificity of the peptidoglycan MurE ligase from Erysipelothrix rhusiopathiae.

Patin D, Turk S, Barreteau H, Mainardi JL, Arthur M, Gobec S, Mengin-Lecreulx D, Blanot D.

Biochimie. 2016 Feb;121:209-18. doi: 10.1016/j.biochi.2015.12.006. Epub 2015 Dec 14.

PMID:
26700151
16.

Furan-based benzene mono- and dicarboxylic acid derivatives as multiple inhibitors of the bacterial Mur ligases (MurC-MurF): experimental and computational characterization.

Perdih A, Hrast M, Pureber K, Barreteau H, Grdadolnik SG, Kocjan D, Gobec S, Solmajer T, Wolber G.

J Comput Aided Mol Des. 2015 Jun;29(6):541-60. doi: 10.1007/s10822-015-9843-6. Epub 2015 Apr 8.

PMID:
25851408
17.

MurD enzymes: some recent developments.

Šink R, Barreteau H, Patin D, Mengin-Lecreulx D, Gobec S, Blanot D.

Biomol Concepts. 2013 Dec;4(6):539-56. doi: 10.1515/bmc-2013-0024. Review.

PMID:
25436755
18.

Benzene-1,3-dicarboxylic acid 2,5-dimethylpyrrole derivatives as multiple inhibitors of bacterial Mur ligases (MurC-MurF).

Perdih A, Hrast M, Barreteau H, Gobec S, Wolber G, Solmajer T.

Bioorg Med Chem. 2014 Aug 1;22(15):4124-34. doi: 10.1016/j.bmc.2014.05.058. Epub 2014 Jun 2.

PMID:
24953950
19.

Deciphering the metabolism of undecaprenyl-phosphate: the bacterial cell-wall unit carrier at the membrane frontier.

Manat G, Roure S, Auger R, Bouhss A, Barreteau H, Mengin-Lecreulx D, Touzé T.

Microb Drug Resist. 2014 Jun;20(3):199-214. doi: 10.1089/mdr.2014.0035. Epub 2014 May 5. Review.

20.

Inhibitor design strategy based on an enzyme structural flexibility: a case of bacterial MurD ligase.

Perdih A, Hrast M, Barreteau H, Gobec S, Wolber G, Solmajer T.

J Chem Inf Model. 2014 May 27;54(5):1451-66. doi: 10.1021/ci500104m. Epub 2014 Apr 28.

PMID:
24724969
21.

Design, synthesis and evaluation of second generation MurF inhibitors based on a cyanothiophene scaffold.

Hrast M, Anderluh M, Knez D, Randall CP, Barreteau H, O'Neill AJ, Blanot D, Gobec S.

Eur J Med Chem. 2014 Feb 12;73:83-96. doi: 10.1016/j.ejmech.2013.11.031. Epub 2013 Dec 12.

PMID:
24384549
22.

Specificity determinants for lysine incorporation in Staphylococcus aureus peptidoglycan as revealed by the structure of a MurE enzyme ternary complex.

Ruane KM, Lloyd AJ, Fülöp V, Dowson CG, Barreteau H, Boniface A, Dementin S, Blanot D, Mengin-Lecreulx D, Gobec S, Dessen A, Roper DI.

J Biol Chem. 2013 Nov 15;288(46):33439-48. doi: 10.1074/jbc.M113.508135. Epub 2013 Sep 24.

23.

Biochemical characterization of MurF from Streptococcus pneumoniae and the identification of a new MurF inhibitor through ligand-based virtual screening.

Turk S, Hrast M, Sosic I, Barreteau H, Mengin-Lecreulx D, Blanot D, Gobec S.

Acta Chim Slov. 2013;60(2):294-9.

PMID:
23878932
24.

Structure-activity relationships of new cyanothiophene inhibitors of the essential peptidoglycan biosynthesis enzyme MurF.

Hrast M, Turk S, Sosič I, Knez D, Randall CP, Barreteau H, Contreras-Martel C, Dessen A, O'Neill AJ, Mengin-Lecreulx D, Blanot D, Gobec S.

Eur J Med Chem. 2013 Aug;66:32-45. doi: 10.1016/j.ejmech.2013.05.013. Epub 2013 May 21.

PMID:
23786712
25.

[Severe poisonings in intensive care unit: study of announced substances in 2011].

Hinojosa R, Baud F, Marque S, Barreteau H.

Ann Pharm Fr. 2013 May;71(3):174-85. doi: 10.1016/j.pharma.2013.02.002. Epub 2013 Mar 12. French.

PMID:
23622696
26.

The binding mode of second-generation sulfonamide inhibitors of MurD: clues for rational design of potent MurD inhibitors.

Simčič M, Sosič I, Hodošček M, Barreteau H, Blanot D, Gobec S, Grdadolnik SG.

PLoS One. 2012;7(12):e52817. doi: 10.1371/journal.pone.0052817. Epub 2012 Dec 20.

27.

Synthetic tripeptides as alternate substrates of murein peptide ligase (Mpl).

Hervé M, Kovač A, Cardoso C, Patin D, Brus B, Barreteau H, Mengin-Lecreulx D, Gobec S, Blanot D.

Biochimie. 2013 Jun;95(6):1120-6. doi: 10.1016/j.biochi.2012.12.011. Epub 2012 Dec 25.

PMID:
23270797
28.

Colicin M, a peptidoglycan lipid-II-degrading enzyme: potential use for antibacterial means?

Touzé T, Barreteau H, El Ghachi M, Bouhss A, Barnéoud-Arnoulet A, Patin D, Sacco E, Blanot D, Arthur M, Duché D, Lloubès R, Mengin-Lecreulx D.

Biochem Soc Trans. 2012 Dec 1;40(6):1522-7. doi: 10.1042/BST20120189.

PMID:
23176510
29.

Functional and structural characterization of PaeM, a colicin M-like bacteriocin produced by Pseudomonas aeruginosa.

Barreteau H, Tiouajni M, Graille M, Josseaume N, Bouhss A, Patin D, Blanot D, Fourgeaud M, Mainardi JL, Arthur M, van Tilbeurgh H, Mengin-Lecreulx D, Touzé T.

J Biol Chem. 2012 Oct 26;287(44):37395-405. doi: 10.1074/jbc.M112.406439. Epub 2012 Sep 12.

30.

Production of intracellular heparosan and derived oligosaccharides by lyase expression in metabolically engineered E. coli K-12.

Barreteau H, Richard E, Drouillard S, Samain E, Priem B.

Carbohydr Res. 2012 Oct 1;360:19-24. doi: 10.1016/j.carres.2012.07.013. Epub 2012 Jul 27.

PMID:
22975275
31.

MurD enzymes from different bacteria: evaluation of inhibitors.

Barreteau H, Sosič I, Turk S, Humljan J, Tomašić T, Zidar N, Hervé M, Boniface A, Peterlin-Mašič L, Kikelj D, Mengin-Lecreulx D, Gobec S, Blanot D.

Biochem Pharmacol. 2012 Sep 1;84(5):625-32. doi: 10.1016/j.bcp.2012.06.006. Epub 2012 Jun 15.

PMID:
22705647
32.

Characterization of colicin M and its orthologs targeting bacterial cell wall peptidoglycan biosynthesis.

Barreteau H, El Ghachi M, Barnéoud-Arnoulet A, Sacco E, Touzé T, Duché D, Gérard F, Brooks M, Patin D, Bouhss A, Blanot D, van Tilbeurgh H, Arthur M, Lloubès R, Mengin-Lecreulx D.

Microb Drug Resist. 2012 Jun;18(3):222-9. doi: 10.1089/mdr.2011.0230. Epub 2012 Mar 20. Review.

PMID:
22432709
33.

Colicin M hydrolyses branched lipids II from Gram-positive bacteria.

Patin D, Barreteau H, Auger G, Magnet S, Crouvoisier M, Bouhss A, Touzé T, Arthur M, Mengin-Lecreulx D, Blanot D.

Biochimie. 2012 Apr;94(4):985-90. doi: 10.1016/j.biochi.2011.12.019. Epub 2011 Dec 26.

PMID:
22210388
34.

Second-generation sulfonamide inhibitors of D-glutamic acid-adding enzyme: activity optimisation with conformationally rigid analogues of D-glutamic acid.

Sosič I, Barreteau H, Simčič M, Sink R, Cesar J, Zega A, Grdadolnik SG, Contreras-Martel C, Dessen A, Amoroso A, Joris B, Blanot D, Gobec S.

Eur J Med Chem. 2011 Jul;46(7):2880-94. doi: 10.1016/j.ejmech.2011.04.011. Epub 2011 Apr 9.

35.

X-ray structure and site-directed mutagenesis analysis of the Escherichia coli colicin M immunity protein.

Gérard F, Brooks MA, Barreteau H, Touzé T, Graille M, Bouhss A, Blanot D, van Tilbeurgh H, Mengin-Lecreulx D.

J Bacteriol. 2011 Jan;193(1):205-14. doi: 10.1128/JB.01119-10. Epub 2010 Oct 29.

36.

Toxicity of the colicin M catalytic domain exported to the periplasm is FkpA independent.

Barnéoud-Arnoulet A, Barreteau H, Touzé T, Mengin-Lecreulx D, Lloubès R, Duché D.

J Bacteriol. 2010 Oct;192(19):5212-9. doi: 10.1128/JB.00431-10. Epub 2010 Jul 30.

37.

Purification and biochemical characterization of Mur ligases from Staphylococcus aureus.

Patin D, Boniface A, Kovač A, Hervé M, Dementin S, Barreteau H, Mengin-Lecreulx D, Blanot D.

Biochimie. 2010 Dec;92(12):1793-800. doi: 10.1016/j.biochi.2010.07.009. Epub 2010 Jul 24.

PMID:
20659527
38.

Deciphering the catalytic domain of colicin M, a peptidoglycan lipid II-degrading enzyme.

Barreteau H, Bouhss A, Gérard F, Duché D, Boussaid B, Blanot D, Lloubès R, Mengin-Lecreulx D, Touzé T.

J Biol Chem. 2010 Apr 16;285(16):12378-89. doi: 10.1074/jbc.M109.093583. Epub 2010 Feb 16.

39.

Human- and plant-pathogenic Pseudomonas species produce bacteriocins exhibiting colicin M-like hydrolase activity towards peptidoglycan precursors.

Barreteau H, Bouhss A, Fourgeaud M, Mainardi JL, Touzé T, Gérard F, Blanot D, Arthur M, Mengin-Lecreulx D.

J Bacteriol. 2009 Jun;191(11):3657-64. doi: 10.1128/JB.01824-08. Epub 2009 Apr 3.

40.

Quantitative high-performance liquid chromatography analysis of the pool levels of undecaprenyl phosphate and its derivatives in bacterial membranes.

Barreteau H, Magnet S, El Ghachi M, Touzé T, Arthur M, Mengin-Lecreulx D, Blanot D.

J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Jan 15;877(3):213-20. doi: 10.1016/j.jchromb.2008.12.010. Epub 2008 Dec 11.

PMID:
19110475
41.

Cytoplasmic steps of peptidoglycan biosynthesis.

Barreteau H, Kovac A, Boniface A, Sova M, Gobec S, Blanot D.

FEMS Microbiol Rev. 2008 Mar;32(2):168-207. doi: 10.1111/j.1574-6976.2008.00104.x. Epub 2008 Feb 11. Review.

42.

Colicin M exerts its bacteriolytic effect via enzymatic degradation of undecaprenyl phosphate-linked peptidoglycan precursors.

El Ghachi M, Bouhss A, Barreteau H, Touzé T, Auger G, Blanot D, Mengin-Lecreulx D.

J Biol Chem. 2006 Aug 11;281(32):22761-72. Epub 2006 Jun 15.

43.

A rapid method for determining the antimicrobial activity of novel natural molecules.

Barreteau H, Mandoukou L, Adt I, Gaillard I, Courtois B, Courtois J.

J Food Prot. 2004 Sep;67(9):1961-4.

PMID:
15453590
44.

[Fluctuations of serotonin and its metabolites in the lung and intestinal mucosa in the rat infected with Nippostrongylus brasiliensis].

Grosclaude JM, Goudey-Perrière F, Gayral P, Jacquot C, Barreteau H.

Bull Soc Pathol Exot. 1998;91(2):133-7. French.

PMID:
9642465
45.

Levels of biogenic amines in larvae and adults of the rat hookworm, Nippostrongylus brasiliensis (Nematoda).

Goudey-Perrière F, Grosclaude JM, Nembo B, Barreteau H, Jacquot C, Gayral P.

Comp Biochem Physiol A Physiol. 1997 Nov;118(3):615-23.

PMID:
9406438
46.

[Comparative data on biogenic amines and GABA in three Rodents Filariae].

Barreteau H, Goudey-Perrière F, Jacquot C, Milne-Edwards SD, Gayral P.

C R Acad Sci III. 1991;312(8):415-20. French.

PMID:
1905185
47.

Biogenic amines in newly-ecdysed cockroaches.

Barreteau H, Perrière C, Brousse-Gaury P, Trouvin JH, Binet P, Gayral P, Jacquot C, Goudey-Perrière F.

Comp Biochem Physiol C. 1991;98(2-3):399-405.

PMID:
1712692
48.

Indolamines in the cockroach Blaberus craniifer Burm. nervous system--II. Fed and crowded young males in comparison with females.

Goudey-Perrière F, Barreteau H, Perrière C, Gayral P, Jacquot C, Brousse-Gaury P.

Comp Biochem Physiol C. 1991;100(3):457-61.

PMID:
1687542
49.

Biogenic amine levels in the cockroach Blaberus craniifer Burm. nervous system.

Goudey-Perrière F, Barreteau H, Perrière C, Gayral P, Jacquot C, Brousse-Gaury P.

Comp Biochem Physiol C. 1991;100(3):451-5.

PMID:
1687541
50.

Biogenic amines and GABA in the larval and adult forms of the nematode Nippostrongylus brasiliensis.

Barreteau H, Trouvin JH, Goudey-Perrière F, Jacquot C, Gayral P.

Comp Biochem Physiol C. 1991;100(3):445-9.

PMID:
1687540

Supplemental Content

Loading ...
Support Center